id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2009-N-0247-0310,FDA,FDA-2009-N-0247,"Food and Drug Administration Transparency Initiative: Increasing
Public Access to the Food and Drug Administration’s Compliance and
Enforcement Data; Availability",Notice,General Notice,2014-04-23T04:00:00Z,2014,4,2014-04-23T04:00:00Z,,2014-04-23T15:45:21Z,2014-09188,0,0,09000064816c39bd
FDA-2009-N-0247-0301,FDA,FDA-2009-N-0247,Transparency Initiative: Exploratory Program to Increase Access to Compliance and Enforcement Data,Notice,General Notice,2012-02-01T05:00:00Z,2012,2,2012-02-01T05:00:00Z,,2012-02-01T14:35:20Z,2012-02184,0,0,0900006480fab1d4
FDA-2009-N-0247-0302,FDA,FDA-2009-N-0247,FDA Transparency Initiative: Exploratory Program to Increase Access to the Agency’s Compliance and Enforcement Data - Report,Supporting & Related Material,Report,2012-02-01T05:00:00Z,2012,2,,,2012-02-01T16:11:31Z,,0,0,0900006480faae1a
FDA-2009-N-0247-0300,FDA,FDA-2009-N-0247,Report on Good Guidance Practices Improving Efficiency and Transparency; Availability,Notice,Availability of Document,2011-12-30T05:00:00Z,2011,12,2011-12-30T05:00:00Z,2012-02-29T04:59:59Z,2011-12-30T14:36:05Z,2011-33573,0,0,0900006480f8b7c2
FDA-2009-N-0247-0282,FDA,FDA-2009-N-0247,Food and Drug Administration Transparency Initiative: Draft Proposals for Public Comment to Increase Transparency By Promoting Greater Access to the Agency’s Compliance and Enforcement Data - Report,Other,Report,2011-10-04T04:00:00Z,2011,10,2011-10-04T04:00:00Z,2011-12-03T04:59:59Z,2012-09-24T13:51:34Z,,0,0,0900006480f4b7a6
FDA-2009-N-0247-0281,FDA,FDA-2009-N-0247,Food and Drug Administration Transparency Initiative: Draft Proposals for Public Comment to Increase Transparency By Promoting Greater Access to the Agency’s Compliance and Enforcement Data; Availability,Notice,Notice of Availability,2011-10-04T04:00:00Z,2011,10,2011-10-04T04:00:00Z,2011-12-03T04:59:59Z,2011-10-04T14:23:45Z,2011-25354,0,0,0900006480f4b687
FDA-2009-N-0247-0278,FDA,FDA-2009-N-0247,BioMarin Pharmaceutical Inc. - Request for Appearance,Other,Appearance Request,2011-07-08T04:00:00Z,2011,7,2011-07-08T04:00:00Z,,2013-07-27T22:56:23Z,,0,0,0900006480a3be58
FDA-2009-N-0247-0277,FDA,FDA-2009-N-0247,Nielsen Hobbs - Request for Appearance,Other,Appearance Request,2011-07-08T04:00:00Z,2011,7,2011-07-08T04:00:00Z,,2013-08-11T03:04:32Z,,0,0,0900006480a3bdd5
FDA-2009-N-0247-0276,FDA,FDA-2009-N-0247,BioMarin Pharmaceutical Inc. - Request for Appearance,Other,Appearance Request,2011-07-08T04:00:00Z,2011,7,2011-07-08T04:00:00Z,,2013-08-11T04:35:53Z,,0,0,0900006480a3bdae
FDA-2009-N-0247-0260,FDA,FDA-2009-N-0247,FDA Transparency Initiative: Improving Transparency to Regulated Industry,Notice,N-Notice,2011-01-07T05:00:00Z,2011,1,2011-01-07T05:00:00Z,2011-03-09T04:59:59Z,2011-03-03T20:47:30Z,2011-71,0,0,0900006480bc6d30
FDA-2009-N-0247-0261,FDA,FDA-2009-N-0247,"Phase III Report_Final, January 2011 - [FDA Transparency Initiative: Improving Transparency to Regulated Industry] - Report",Other,RPT-Report,2011-01-07T05:00:00Z,2011,1,2011-01-07T05:00:00Z,,2011-01-07T15:34:54Z,,0,0,0900006480bc65f2
FDA-2009-N-0247-0256,FDA,FDA-2009-N-0247,Blue Cross Blue Shield Association (BCBSA) re FDA-2009-N-0247-0222,Supporting & Related Material,Reference (external attachments),2010-07-28T04:00:00Z,2010,7,,,2011-09-20T15:52:34Z,,0,0,0900006480b214bb
FDA-2009-N-0247-0218,FDA,FDA-2009-N-0247,FDA Transparency Initiative: Draft Proposals for Public Comment Regarding Disclosure Policies of the U.S. Food and Drug Administration; Availability,Notice,N-Notice,2010-05-21T04:00:00Z,2010,5,2010-05-21T04:00:00Z,2010-07-21T03:59:59Z,2010-07-22T21:49:25Z,2010-12314,0,0,0900006480af19ad
FDA-2009-N-0247-0184,FDA,FDA-2009-N-0247,Food and Drug Administration Transparency Task Force; Request for Comments,Notice,N-Notice,2010-03-12T05:00:00Z,2010,3,2010-03-12T05:00:00Z,2010-04-13T03:59:59Z,2010-04-13T22:14:36Z,2010-05377,0,0,0900006480abc274
FDA-2009-N-0247-0183,FDA,FDA-2009-N-0247,Summary of Listening Sessions with Industry - Reference,Other,REF-Reference Material (internal attachments),2010-03-11T05:00:00Z,2010,3,2010-03-11T05:00:00Z,,2013-08-11T04:38:30Z,,0,0,0900006480abb6c5
FDA-2009-N-0247-0178,FDA,FDA-2009-N-0247,"Freya Koss - ""FDA Public Meeting on Transparency, Nov. 3, 2009"" - Testimony",Other,TS-Testimony,2009-11-16T05:00:00Z,2009,11,2009-11-16T05:00:00Z,,2013-07-27T22:59:55Z,,0,0,0900006480a58bc6
FDA-2009-N-0247-0158,FDA,FDA-2009-N-0247,"Final Versions - Three Hypothetical Case Studies, Presentation Date November 3, 2009 (Food and Drug Administration Transparency Task Force; Public Meeting;Request for Comments) - Reference",Supporting & Related Material,Reference (internal unless indicated),2009-11-13T05:00:00Z,2009,11,,,2011-09-20T15:44:22Z,,0,0,0900006480a51ccd
FDA-2009-N-0247-0136,FDA,FDA-2009-N-0247,Food and Drug Administration Transparency Task Force; Public Meeting; Request for Comments,Notice,NM-Notice of Meeting,2009-10-05T04:00:00Z,2009,10,2009-10-05T04:00:00Z,2009-11-07T04:59:59Z,2010-04-13T22:17:20Z,E9-23916,0,0,0900006480a3ba54
FDA-2009-N-0247-0128,FDA,FDA-2009-N-0247,Food and Drug Administration Transparency Task Force; Reopening Comment Period,Notice,NEC-Notice of Extension,2009-08-18T04:00:00Z,2009,8,2009-08-18T04:00:00Z,2009-11-07T04:59:59Z,2010-04-13T22:15:59Z,E9-19778,0,0,0900006480a0c1f1
FDA-2009-N-0247-0124,FDA,FDA-2009-N-0247,American Association for Health Freedom (AAHF) to the Division of Dockets Management - [Multiple Submitters=801] - Letter,Other,LET-Letter,2009-08-14T04:00:00Z,2009,8,2009-08-14T04:00:00Z,,2013-07-27T22:51:18Z,,0,0,0900006480a0367a
FDA-2009-N-0247-0079,FDA,FDA-2009-N-0247,"Natural Products Association (NPA) - ""Comments for FDA Transparency Meeting (D.Fabricant)"" - [Public Meeting FDA Transparency Task Force, June 24, 2009] - Testimony",Other,TS-Testimony,2009-07-14T04:00:00Z,2009,7,2009-07-14T04:00:00Z,,2013-07-27T22:48:11Z,,0,0,09000064809e5b1c
FDA-2009-N-0247-0078,FDA,FDA-2009-N-0247,"American Epilepsy Society (Dr. S.Schachter) - [Public Meeting FDA Transparency Task Force, June 24, 2009] - Testimony",Other,TS-Testimony,2009-07-10T04:00:00Z,2009,7,2009-07-10T04:00:00Z,,2013-08-11T03:03:04Z,,0,0,09000064809ed97b
FDA-2009-N-0247-0070,FDA,FDA-2009-N-0247,"Public Meeting FDA Transparency Task Force, June 24, 2009 - Transcript",Other,TR-Transcript,2009-07-01T04:00:00Z,2009,7,2009-07-01T04:00:00Z,,2013-08-11T01:28:16Z,,0,0,09000064809e7abb
FDA-2009-N-0247-0066,FDA,FDA-2009-N-0247,"Medical Device Safety Institute - ""FDA Transparency:Suggestions for Improving Public Health (W.Maisel)"" - [Public Meeting FDA Transparency Task Force, June 24, 2009] - Testimony",Other,TS-Testimony,2009-07-01T04:00:00Z,2009,7,2009-06-03T04:00:00Z,2009-06-04T03:59:59Z,2013-08-11T04:34:05Z,,0,0,09000064809e5699
FDA-2009-N-0247-0071,FDA,FDA-2009-N-0247,"Milford Medical Laboratory (S.Lee) - [Public Meeting FDA Transparency Task Force, June 24, 2009] - Testimony",Other,TS-Testimony,2009-07-01T04:00:00Z,2009,7,2009-07-01T04:00:00Z,,2013-07-27T22:48:10Z,,0,0,09000064809e5666
FDA-2009-N-0247-0054,FDA,FDA-2009-N-0247,"Breast Cancer Fund - ""Testimony for the FDA Transparency Task Force (E.Napalo)"" - [Public Meeting FDA Transparency Task Force, June 24, 2009] - Testimony",Other,TS-Testimony,2009-07-01T04:00:00Z,2009,7,2009-07-01T04:00:00Z,,2013-07-27T22:48:10Z,,0,0,09000064809e563c
FDA-2009-N-0247-0053,FDA,FDA-2009-N-0247,"IDSN (International Document Solutions Network) - ""Technology Improves Food Safety Communication (B.Kelser)"" - [Public Meeting FDA Transparency Task Force, June 24, 2009] - Testimony",Other,TS-Testimony,2009-07-01T04:00:00Z,2009,7,2009-06-03T04:00:00Z,2009-06-04T03:59:59Z,2013-08-11T04:34:05Z,,0,0,09000064809e5639
FDA-2009-N-0247-0061,FDA,FDA-2009-N-0247,"Bray Patrick-Lake - ""Enhancing Transparency via Patient Advocacy in FDA Regulated Clinical Research Trials"" [Public Meeting FDA Transparency Task Force, June 24, 2009] - Testimony",Other,TS-Testimony,2009-07-01T04:00:00Z,2009,7,2009-07-01T04:00:00Z,,2013-07-27T22:48:11Z,,0,0,09000064809e5b15
FDA-2009-N-0247-0068,FDA,FDA-2009-N-0247,"David Lim, Ph.D. RAC - ""Transparencey 101""-  [Public Meeting FDA Transparency Task Force, June 24, 2009] - Testimony",Other,TS-Testimony,2009-07-01T04:00:00Z,2009,7,2009-07-01T04:00:00Z,,2013-07-27T22:48:13Z,,0,0,09000064809e630d
FDA-2009-N-0247-0059,FDA,FDA-2009-N-0247,"Genetic Alliance - ""Transforming Health Through Genetics Promoting an Environment of Openness (K.Zonno)"" [Public Meeting FDA Transparency Task Force, June 24, 2009] - Testimony",Other,TS-Testimony,2009-07-01T04:00:00Z,2009,7,2009-06-03T04:00:00Z,2009-06-04T03:59:59Z,2013-07-27T22:48:11Z,,0,0,09000064809e5b0d
FDA-2009-N-0247-0051,FDA,FDA-2009-N-0247,"Microsoft® - ""Enabling Transparent Goverance With Gov 2.0 (C.Brubaker)""  [Public Meeting FDA Transparency Task Force, June 24, 2009] - Testimony",Other,TS-Testimony,2009-07-01T04:00:00Z,2009,7,2009-06-03T04:00:00Z,2009-06-04T03:59:59Z,2013-07-27T22:48:10Z,,0,0,09000064809e563e
FDA-2009-N-0247-0064,FDA,FDA-2009-N-0247,"The Senior Citizens League ""Statement of S.Benton"" [Public Meeting FDA Transparency Task Force, June 24, 2009] - Testimony",Other,TS-Testimony,2009-07-01T04:00:00Z,2009,7,2009-07-01T04:00:00Z,,2013-08-11T04:34:06Z,,0,0,09000064809e5b20
FDA-2009-N-0247-0060,FDA,FDA-2009-N-0247,"Medical Device Manufacturers Association (MDMA) - ""Recommendations to Promote Predictability and Transparency (M.Leahy)"" - [Public Meeting FDA Transparency Task Force, June 24, 2009] - Testimony",Other,TS-Testimony,2009-07-01T04:00:00Z,2009,7,2009-06-03T04:00:00Z,2009-06-04T03:59:59Z,2013-07-27T22:48:11Z,,0,0,09000064809e5b11
FDA-2009-N-0247-0067,FDA,FDA-2009-N-0247,"The Tatia Oden French Memorial Foundation - "" Recommendations to the Transparency Task Force (K.Oden)"" - [Public Meeting FDA Transparency Task Force, June 24, 2009] - Testimony",Other,TS-Testimony,2009-07-01T04:00:00Z,2009,7,2009-06-03T04:00:00Z,2009-06-04T03:59:59Z,2013-07-27T22:48:13Z,,0,0,09000064809e630b
FDA-2009-N-0247-0058,FDA,FDA-2009-N-0247,"Produce Marketing Association - ""Comments for Food and Drug Administration Transparency Task Force (K.Means)"" [FDA Transparency Task Force, June 24, 2009] - Testimony",Other,TS-Testimony,2009-07-01T04:00:00Z,2009,7,2009-06-03T04:00:00Z,2009-06-04T03:59:59Z,2013-07-27T22:48:10Z,,0,0,09000064809e566b
FDA-2009-N-0247-0052,FDA,FDA-2009-N-0247,"Advanced Medical Technology Association (AdvaMed) - ""FDA’s Public Meeting on Transparency (J.Trunzo)"" - [Public Meeting FDA Transparency Task Force, June 24, 2009] - Testimony",Other,TS-Testimony,2009-07-01T04:00:00Z,2009,7,2009-06-03T04:00:00Z,2009-06-04T03:59:59Z,2013-07-27T22:48:10Z,,0,0,09000064809e5620
FDA-2009-N-0247-0057,FDA,FDA-2009-N-0247,"Compliance Media Inc. - ""FDA: A History: Transparency Taskforce (G.Meyer)"" - [Public Meeting FDA Transparency Task Force, June 24, 2009] - Testimony",Other,TS-Testimony,2009-07-01T04:00:00Z,2009,7,2009-06-03T04:00:00Z,2009-06-04T03:59:59Z,2013-08-11T03:02:48Z,,0,0,09000064809e5669
FDA-2009-N-0247-0055,FDA,FDA-2009-N-0247,"Center for Science in the Public Interest - ""FDA Transparency Task Force: Recommendations from CSPI (S.Klein)"" - [Public Meeting FDA Transparency Task Force, June 24, 2009] - Testimony",Other,TS-Testimony,2009-07-01T04:00:00Z,2009,7,2009-06-03T04:00:00Z,2009-06-04T03:59:59Z,2013-07-27T22:48:11Z,,0,0,09000064809e5a5c
FDA-2009-N-0247-0062,FDA,FDA-2009-N-0247,"Physicians Committee for Responsible Medicine (PCRM) ""Lessons from Bisphenol A (J.Francer/N.Beck)"" - [Public meeting FDA Transparency Task Force, June 24, 2009] - Testimony",Other,TS-Testimony,2009-07-01T04:00:00Z,2009,7,2009-07-01T04:00:00Z,,2013-07-27T22:48:11Z,,0,0,09000064809e5b19
FDA-2009-N-0247-0063,FDA,FDA-2009-N-0247,"Pew Prescription Project - ""Comments of Pew Prescription Project et al (A.Coukell)"" - [FDA Transparency Task Force, June 24, 2009] - Testimony",Other,TS-Testimony,2009-07-01T04:00:00Z,2009,7,2009-07-01T04:00:00Z,,2013-08-11T03:02:48Z,,0,0,09000064809e5b1e
FDA-2009-N-0247-0056,FDA,FDA-2009-N-0247,See FDA-2009-N-0247-0094,Supporting & Related Material,,2009-07-01T00:00:00Z,2009,7,,,2009-08-05T23:30:28Z,,0,1,09000064809e5664
FDA-2009-N-0247-0001,FDA,FDA-2009-N-0247,Food and Drug Administration Transparency Task Force; Public Meeting,Notice,NM-Notice of Meeting,2009-06-03T04:00:00Z,2009,6,2009-06-03T04:00:00Z,2009-08-08T03:59:59Z,2009-07-01T16:59:01Z,E9-12902,0,0,09000064809c3c29